triazoles has been researched along with nnd 502 in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 10 (50.00) | 24.3611 |
| 2020's | 10 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jim, SC; Kircik, LH; Routt, ET; Zeichner, JA | 1 |
| Hussar, DA | 1 |
| Koga, H; Maeda, J; Makimura, K; Nanjoh, Y; Toga, T; Tsuboi, R | 1 |
| Koski, R; Maki, K; Nybo, SE; Saunders, J | 1 |
| Rosen, T | 1 |
| Hirayanagi, K; Imai, A; Iwanaga, T; Kubota, N; Miyamae, A; Shibuya, K; Shimamura, T | 1 |
| Ahmadi, B; Alshahni, MM; Ansari, S; Badali, H; Makimura, K; Mirhendi, H; Rezaei-Matehkolaei, A; Shokoohi, GR; Vaezi, A | 1 |
| Hasuko, M; Hirano, H; Inagaki, K; Motoba, K; Shiomi, R; Takahashi, Y; Tsuboi, R | 1 |
| Kawai, M | 1 |
| Harada, K; Inagaki, K; Kampirapap, K; Koga, H; Maeda, J; Makimura, K; Nanjoh, Y; Neki, D; Reangchainam, S; Tsuboi, R; Yuasa, K | 1 |
| Kuwano, Y; Sei, Y; Shimoyama, H | 1 |
| Abou El-Alamin, MM; Aboul-Enein, HY; Atia, MA; Sultan, MA | 1 |
| Aala, F; Badali, H; Barac, A; Daie Ghazvini, R; Fatahi, N; Ghaffari, M; Hashemi, SJ; Izadi, A; Khodavaisy, S; Rezaie, S; Salehi, Z; Taran, M | 1 |
| Fujimoto, K; Mayumi, N; Otsuka, Y; Saeki, H; Yamaguchi, H | 1 |
| Gharaghani, M; Taghipour, S; Zarei Mahmoudabadi, A | 1 |
| Hirakawa, S; Inagaki, K; Nagai, H; Nakamura, A | 1 |
| Ansari, S; Goodarzi, S; Javidnia, J; Maryami, F; Mirhendi, H; Rasekh-Jahromi, A; Rezaei-Matehkolaei, A; Romeo, O; Shokoohi, G | 1 |
| Guillot, J; Rezaei-Matehkolaei, A; Shamsizadeh, F; Shariat Nabavi, M; Taghipour, S; Zarei Mahmoudabadi, A | 1 |
| Masumoto, A; Matsuda, Y; Nakamura, S; Sugiura, K; Takagi, M; Tatsumi, Y | 1 |
| Abastabar, M; Badali, H; Bonifaz, A; Fahal, A; Lim, W; Nyuykonge, B; van Amelsvoort, L; van de Sande, W; Verbon, A | 1 |
4 review(s) available for triazoles and nnd 502
| Article | Year |
|---|---|
What is new in fungal pharmacotherapeutics?
Topics: Allylamine; Antifungal Agents; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Education, Medical, Continuing; Humans; Imidazoles; Itraconazole; Onychomycosis; Tinea Pedis; Triazoles | 2014 |
New drugs 2015, part 3.
Topics: Acids, Carbocyclic; Benzoxazines; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cephalosporins; Cyclopentanes; Drug Approval; Drug Combinations; Drug Therapy; Glucagon-Like Peptides; Guanidines; Humans; Imidazoles; Immunoglobulin Fc Fragments; Interferon-beta; Isoquinolines; Penicillanic Acid; Polyethylene Glycols; Pyridines; Quinuclidines; Recombinant Fusion Proteins; Tazobactam; Triazoles; United States; United States Food and Drug Administration | 2015 |
Tavaborole, Efinaconazole, and Luliconazole: Three New Antimycotic Agents for the Treatment of Dermatophytic Fungi.
Topics: Administration, Topical; Animals; Antifungal Agents; Arthrodermataceae; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Dermatomycoses; Humans; Imidazoles; Microbial Sensitivity Tests; Randomized Controlled Trials as Topic; Treatment Outcome; Triazoles | 2017 |
Characteristics and Efficacy of Two Topical Therapeutic Agents for Onychomycosis.
Topics: Administration, Topical; Antifungal Agents; Drug Resistance, Fungal; Humans; Imidazoles; Keratins; Nails; Onychomycosis; Solutions; Triazoles; Trichophyton | 2019 |
16 other study(ies) available for triazoles and nnd 502
| Article | Year |
|---|---|
[In vitro Antifungal Activity of Luliconazole against Trichophyton spp].
Topics: Allylamine; Antifungal Agents; Drug Resistance, Fungal; Imidazoles; Microbial Sensitivity Tests; Naphthalenes; Pyridines; Terbinafine; Thiocarbamates; Triazoles; Trichophyton | 2016 |
Tinea and Onychomycosis.
Topics: Administration, Cutaneous; Antifungal Agents; Humans; Imidazoles; Onychomycosis; Recurrence; Tinea; Tinea Pedis; Triazoles | 2016 |
Comparison of Characteristics of Two Topical Therapeutic Agents for Onychomycosis.
Topics: Administration, Topical; Antifungal Agents; Dose-Response Relationship, Drug; Drug Discovery; Drug Resistance, Fungal; Humans; Imidazoles; In Vitro Techniques; Nails; Onychomycosis; Solutions; Triazoles; Trichophyton | 2016 |
Topics: Adult; Antifungal Agents; Ascomycota; Child, Preschool; Drug Resistance, Fungal; Female; Humans; Imidazoles; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Triazoles; Yeasts; Young Adult | 2017 |
[Affinity of Luliconazole for Human Nail Derived Keratin].
Topics: Humans; Imidazoles; Keratins; Nails; Onychomycosis; Triazoles | 2017 |
In vitro antifungal activity of luliconazole against nondermatophytic moulds.
Topics: Amphotericin B; Antifungal Agents; Clotrimazole; Fluconazole; Fungi; Humans; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Morpholines; Sequence Analysis, DNA; Terbinafine; Triazoles; Voriconazole | 2020 |
Retrospective Survey of Treatment Outcomes of Efinaconazole 10% Solution and Luliconazole 5% Solution for Onychomycosis in Our Facility.
Topics: Administration, Topical; Adult; Aged; Female; Humans; Imidazoles; Male; Middle Aged; Onychomycosis; Retrospective Studies; Solutions; Treatment Outcome; Triazoles | 2019 |
Novel Application of Pentabromobenzyl Column for Simultaneous Determination of Eight Antifungal Drugs Using High-performance Liquid Chromatography.
Topics: Antifungal Agents; Chromatography, High Pressure Liquid; Clotrimazole; Humans; Hydrocarbons, Brominated; Imidazoles; Ketoconazole; Liquid-Liquid Extraction; Molecular Structure; Thiophenes; Triazoles; Voriconazole | 2020 |
Comparison of in vitro antifungal activity of novel triazoles with available antifungal agents against dermatophyte species caused tinea pedis.
Topics: Antifungal Agents; Arthrodermataceae; Dermatomycoses; Fluconazole; Griseofulvin; Humans; Imidazoles; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Terbinafine; Tinea; Tinea Pedis; Triazoles; Trichophyton; Voriconazole | 2020 |
Contact Dermatitis Caused by Efinaconazole and Luliconazole.
Topics: Administration, Topical; Aged; Antifungal Agents; Dermatitis, Contact; Epitopes; Foot Dermatoses; Humans; Imidazoles; Male; Patch Tests; Triazoles | 2021 |
Molecular identification, biofilm formation and antifungal susceptibility of Rhodotorula spp.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Caspofungin; DNA, Fungal; DNA, Ribosomal Spacer; Fluconazole; Humans; Imidazoles; Itraconazole; Microbial Sensitivity Tests; Phylogeny; Rhodotorula; Species Specificity; Triazoles; Voriconazole | 2020 |
A comparative study between two antifungal agents, Luliconazole and Efinaconazole, of their preventive effects in a Trichophyton-infected guinea pig onychomycosis model.
Topics: Administration, Topical; Animals; Antifungal Agents; Disease Models, Animal; Guinea Pigs; Imidazoles; Male; Specific Pathogen-Free Organisms; Tinea; Triazoles; Trichophyton | 2021 |
Molecular identification and antifungal susceptibility profiles of Candida dubliniensis and Candida africana isolated from vulvovaginal candidiasis: A single-centre experience in Iran.
Topics: Adult; Antifungal Agents; Candida; Candidiasis, Vulvovaginal; DNA, Fungal; Female; Fungal Proteins; Humans; Imidazoles; Iran; Membrane Glycoproteins; Microbial Sensitivity Tests; Middle Aged; Prevalence; Triazoles | 2021 |
In vitro activities of 8 antifungal agents against geophilic dermatophyte isolates.
Topics: Antifungal Agents; Arthrodermataceae; Imidazoles; Itraconazole; Microbial Sensitivity Tests; Terbinafine; Triazoles | 2022 |
A novel method for predicting the efficacy of topical drugs on onychomycosis: A comparison of efinaconazole and luliconazole.
Topics: Administration, Topical; Antifungal Agents; Humans; Imidazoles; Nails; Onychomycosis; Triazoles | 2022 |
Eumycetoma causative agents are inhibited in vitro by luliconazole, lanoconazole and ravuconazole.
Topics: Antifungal Agents; Humans; Imidazoles; Itraconazole; Madurella; Mycetoma; Thiazoles; Triazoles | 2022 |